Gastrointestinal Over-The-Counter (OTC) Drugs Market Trends Report 2025 – For Business Development and Strategy Teams
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Gastrointestinal Over-The-Counter (OTC) Drugs Market Growth in 2025?
The market for over-the-counter (OTC) gastrointestinal drugs has seen robust growth lately. It is projected to expand from $45.73 billion in 2024 to $49.59 billion in 2025, delivering a compound annual growth rate (CAGR) of 8.4%. Factors contributing to the growth during the historic period include the increased incidence of gastrointestinal disorders, a growing tendency among consumers to self-medicate, a rise in the supply of OTC proton pump inhibitors, increased awareness about digestive health, and a growing elderly population susceptible to GI problems.
What Is the Forecast for the Gastrointestinal Over-The-Counter (OTC) Drugs Market Size Through 2029?
In the coming years, the over-the-counter (OTC) drugs market for gastrointestinal issues is likely to experience robust expansion. It’s anticipated to reach $67.88 billion in 2029, showcasing a compound annual growth rate (CAGR) of 8.2%. Several factors fuel this projected growth, such as increasing demand for quick symptom relief, greater penetration of online pharmacies, wider access to combination OTC therapies, heightened focus on maintaining gut microbiome health, and enhanced marketing along with awareness initiatives from leading market players. Key trends shaping the forecast period encompass new generations of rapid-acting antacids, innovative probiotic-based OTC offerings, inclusion of herbal ingredients in digestive treatments, progress in dose-accuracy and portable packaging, and the introduction of sustained-release therapies for gastrointestinal conditions.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24547&type=smp
What are the Key Market Players in Gastrointestinal Over-The-Counter (OTC) Drugs Market and How They’re Evolving?
Major companies operating in the gastrointestinal over-the-counter (OTC) drugs market are Pfizer Inc., Procter & Gamble Co., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group plc, Boehringer Ingelheim GmbH, Haleon plc, Sandoz AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy’s Laboratories Ltd.
What Are the Primary Growth Drivers in the Gastrointestinal Over-The-Counter (OTC) Drugs Market?
The escalating occurrence of digestive issues is anticipated to fuel the expansion of the gastrointestinal OTC drugs market in the future. These issues range from conditions affecting the stomach, intestines, and other related organs. The surge in such disorders is predominantly caused by the increased consumption of processed, low-fiber foods that negatively impact gut health and hamper the digestion process. Gastrointestinal OTC drugs aid in alleviating symptoms of these disorders by decreasing stomach acid, promoting regular bowel movements, and boosting gut health. They deliver immediate, handy relief from typical problems like acidity, irregular bowel movements, and digestive discomfort. For example, figures from December 2023 show that over 5,300 individuals were suffering from inflammatory bowel disease (IBD), as reported by IBD Registry Ltd., a non-profit organization based in the UK. This was a significant increase of more than 3,000 cases from the previous year. Thus, the rising occurrence of digestive issues is stimulating the growth of the gastrointestinal OTC drugs market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=24547&type=smp
What Are the Leading Segments in the Global Gastrointestinal Over-The-Counter (OTC) Drugs Industry?
The gastrointestinal over-the-counter (OTC) drugs market covered in this report is segmented –
1) By Product: Antacid, Laxatives, Anti-Diarrheal, Anti-Emetics, Other Products
2) By Formulation: Tablets, Capsules, Liquids, Other Formulations
3) By Indications: Heartburn, Diarrhoea, Constipation, Gastroesophageal Reflux Disease (GERD), Nausea, Vomiting, Motion Sickness, Other Indications
4) By Distribution Channel: Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-Users: Hospitals, Clinics, Home Healthcare, Other End-Users
Subsegments:
1) By Antacid: Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists, Calcium Carbonate, Magnesium Hydroxide, Sodium Bicarbonate, Combination Antacids
2) By Laxatives: Bulk-Forming Laxatives, Stimulant Laxatives, Osmotic Laxatives, Stool Softeners, Lubricant Laxatives
3) By Anti-Diarrheal: Loperamide, Bismuth Subsalicylate, Probiotics, Electrolyte Solutions
4) By Anti-Emetics: Antihistamines, Bismuth Subsalicylate, Phosphorated Carbohydrate Solution, Ginger Supplements
5) By Other Products: Digestive Enzymes, Antispasmodics, Simethicone, Herbal Remedies, Activated Charcoal
What Are the Key Market Trends in the Gastrointestinal Over-The-Counter (OTC) Drugs Industry?
Key players in the gastrointestinal OTC drugs market are focusing their efforts on the creation of advanced products like OTC proton pump inhibitors to offer enduring and effective relief from acid-related conditions. Over-the-counter proton pump inhibitors are medicines which can be acquired without any prescription and work by reducing stomach acid production. These are generally used to alleviate common conditions such as regular heartburn, acid reflux, and gastric ulcers. For example, in March 2025, Japan-based pharmaceutical company Eisai Co., Ltd. obtained approval in Japan to change the status of its Pariet S (rabeprazole sodium 10 mg) from prescription drug to over-the-counter product, marking it as the first OTC proton pump inhibitor in Japan with the same active ingredient and dosage as its prescription counterpart. Pariet S is recommended for treating stomach pain, heartburn, and bloating, facilitating 24-hour relief with a single daily tablet, and striving to fulfill the increasing requirement for effective gastric acid-related treatments due to changes in lifestyle and demographics.
Access The Full Report Here:
What Is the Regional Outlook for the Gastrointestinal Over-The-Counter (OTC) Drugs Market?
North America was the largest region in the gastrointestinal over-the-counter (OTC) drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal over-the-counter (OTC) drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24547
This Report Delivers Insight On:
1. How big is the gastrointestinal over-the-counter (otc) drugs market, and how is it changing globally?
2. Who are the major companies in the gastrointestinal over-the-counter (otc) drugs market, and how are they performing?
3. What are the key opportunities and risks in the gastrointestinal over-the-counter (otc) drugs market right now?
4. Which products or customer segments are growing the most in the gastrointestinal over-the-counter (otc) drugs market?
5. What factors are helping or slowing down the growth of the gastrointestinal over-the-counter (otc) drugs market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
